Théry, C., Ostrowski, M. & Segura, E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9, 581–593 (2009).
Vlassov, A.V., Magdaleno, S., Setterquist, R. & Conrad, R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim. Biophys. Acta 1820, 940–948 (2012).
Thery, C., Amigorena, S., Raposo, G. & Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell. Biol. 30, 3.22 (2006).
Brolo, A.G. Plasmonics for future biosensors. Nat. Photonics 6, 709–713 (2012).
Gordon, R., Sinton, D., Kavanagh, K.L. & Brolo, A.G. A new generation of sensors based on extraordinary optical transmission. Acc. Chem. Res. 41, 1049–1057 (2008).
Im, H., Wittenberg, N.J., Lesuffleur, A., Lindquist, N.C. & Oh, S.-H. Membraneprotein biosensing with plasmonic nanopore arrays and pore-spanning lipid membranes. Chem. Sci. 1, 688–696 (2010).
Escobedo, C. On-chip nanohole array based sensing: a review. Lab Chip 13, 2445–2463 (2013).
Homola, J. Surface plasmon resonance sensors for detection of chemical and biological species. Chem. Rev. 108, 462–493 (2008).
Lee, H.J., Nedelkov, D. & Corn, R.M. Surface plasmon resonance imaging measurements of antibody arrays for the multiplexed detection of low molecular weight protein biomarkers. Anal. Chem. 78, 6504–6510 (2006).
Campbell, M., Sharp, D.N., Harrison, M.T., Denning, R.G. & Turberfield, A.J. Fabrication of photonic crystals for the visible spectrum by holographic lithography. Nature 404, 53–56 (2000).
Im, H., Lesuffleur, A., Lindquist, N.C. & Oh, S.H. Plasmonic nanoholes in a multichannel microarray format for parallel kinetic assays and differential sensing. Anal. Chem. 81, 2854–2859 (2009).
Yanik, A.A. et al. Seeing protein monolayers with naked eye through plasmonic Fano resonances. Proc. Natl. Acad. Sci. USA 108, 11784–11789 (2011).
Shao, H. et al. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat. Med. 18, 1835–1840 (2012).
Tassa, C. et al. Binding affinity and kinetic analysis of targeted small molecule-modified nanoparticles. Bioconjug. Chem. 21, 14–19 (2010).
Anglesio, M.S. et al. Type-specific cell line models for type-specific ovarian cancer research. PLoS ONE 8, e72162 (2013).
Uhlen, M. et al. Towards a knowledge-based human protein atlas. Nat. Biotechnol. 28, 1248–1250 (2010).
Runz, S. et al. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol. Oncol. 107, 563–571 (2007).
Kristiansen, G. et al. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. Am. J. Pathol. 161, 1215–1221 (2002).
Bast, R.C. Jr. et al. CA 125: the past and the future. Int. J. Biol. Markers 13, 179–187 (1998).
Canney, P.A., Wilkinson, P.M., James, R.D. & Moore, M. CA19–9 as a marker for ovarian cancer: alone and in comparison with CA125. Br. J. Cancer 52, 131–133 (1985).
Meden, H. & Kuhn, W. Overexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: a new prognostic factor. Eur. J. Obstet. Gynecol. Reprod. Biol. 71, 173–179 (1997).
Aldovini, D. et al. M-CAM expression as marker of poor prognosis in epithelial ovarian cancer. Int. J. Cancer 119, 1920–1926 (2006).
Psyrri, A. et al. Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer. Clin. Cancer Res. 11, 8637–8643 (2005).
Li, J. et al. Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer. BMC Cancer 9, 244 (2009).
Chu, A.Y., Litzky, L.A., Pasha, T.L., Acs, G. & Zhang, P.J. Utility of D2–40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod. Pathol. 18, 105–110 (2005).
Kipps, E., Tan, D.S.P. & Kaye, S.B. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat. Rev. Cancer 13, 273–282 (2013).
Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654–659 (2007).
Peinado, H. et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883–891 (2012).
MacBeath, G. & Schreiber, S.L. Printing proteins as microarrays for high-throughput function determination. Science 289, 1760–1763 (2000).
Carey, M.S. et al. Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapy. Clin. Cancer Res. 16, 2852–2860 (2010).
Mudanyali, O. et al. Compact, light-weight and cost-effective microscope based on lensless incoherent holography for telemedicine applications. Lab Chip 10, 1417–1428 (2010).
Palik, E.D. Handbook of Optical Constants of Solids. http://www.sciencedirect.com/science/book/9780125444156 (Elsevier, 1998).
Sheehan, K.M. et al. Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol. Cell. Proteomics 4, 346–355 (2005).
Skog, J. et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470–1476 (2008).
Yuan, H. et al. Gold nanostars: surfactant-free synthesis, 3D modelling, and two-photon photoluminescence imaging. Nanotechnology 23, 075102 (2012).
Hill, H.D. & Mirkin, C.A. The bio-barcode assay for the detection of protein and nucleic acid targets using DTT-induced ligand exchange. Nat. Protoc. 1, 324–336 (2006).